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ABSTRACT 3 
In this study, freestanding nanobiocomposite films were obtained by the sequential deposition of 4 
biopolymer-capped silver nanoparticles (AgNPs) and hyaluronic acid (HA). At first, dispersions 5 
of AgNPs decorated with chitosan (CS) or aminocellulose (AC) were synthesized by applying 6 
high intensity ultrasound. These polycationic nanoentities were layer-by-layer assembled with 7 
the HA polyanion to generate stable 3D supramolecular constructs, where the biopolymer-8 
capped AgNPs play the dual role of active agent and structural element. SEM images of the 9 
assemblies revealed gradual increase of thickness with the number of deposited bilayers. The 10 
composites of ≥50 bilayers were safe to human cells and demonstrated 100% antibacterial 11 
activity against Staphylococcus aureus and Escherichia coli. Moreover, the films containing 12 
CSAgNPs brought about the total prevention of biofilm formation reducing the cells surface 13 
adherence by up to 6 logs. Such nanobiocomposites could serve as an effective barrier to control 14 
bacterial growth on injured skin, burns and chronic wounds.  15 
  16 
 3 
   INTRODUCTION 1 
   Composite materials combine multiple components with different physicochemical 2 
characteristics, yielding hybrid structures with a broad range of functionalities and 3 
superior performance compared to their individual constituents. In recent years, important 4 
progress has been made in the field of biomaterial composites, which now have a major 5 
impact in the development of novel biocompatible materials.
1,2
 Advances in 6 
nanobiocomposites fabrication, where one of the building phases shows nanometer range 7 
dimension, are of particular interest due to the unique properties of nanoparticles (NPs) 8 
imparting exceptional chemical, physical and biological characteristics to the 9 
composites.
3
 10 
   Layer-by-layer (LbL) assembling is one of the most rapidly growing technologies for 11 
generating 2D coatings and complex 3D biocomposite materials based on electrostatic 12 
interactions between oppositely charged compounds.
4,5
 LbL assembly is also suitable for 13 
incorporation of one or several functional components including biological molecules and 14 
NPs into materials.
6,7
 These components embedded between the layers can be 15 
subsequently released in a controlled manner from the multilayer construct.
7–9
  16 
   In case of a low number of deposited layers, usually less than 20, the coating must be 17 
anchored on the supporting substrate that maintains its mechanical properties and shape, 18 
behaving as an integrated macroscopic system.
10,11
 By contrast, building higher number 19 
of layers allows for detaching the multilayer system from the substrate and use it as a 3D 20 
freestanding construct. In such case, the embedded components and the number of layers 21 
define the mechanical properties and functionality of these sequentially nano-built macro-22 
structures, without the need for a supporting substrate. Freestanding scaffolds for tissue 23 
 4 
engineering have been successfully developed following this rationale,
12–16
 whereas 1 
stand-alone LbL nanobiocomposite films with antimicrobial activity have been scarcely 2 
reported.
17
 Actually, the development of easily detachable LbL films incorporating nano-3 
sized compounds as active and/or constructive elements is a challenging task and 4 
frequently requires post-fabrication treatments.
18–20
 5 
   In this work, we fabricated hybrid films incorporating aminocellulose (AC) or chitosan 6 
(CS)-capped silver nanoparticles (AgNPs). The goal of assembling biopolymers and 7 
antibacterial inorganic AgNPs is to fabricate safe by design biocompatible films to inhibit 8 
the growth and adhesion of Gram-negative and Gram-positive bacteria, limiting the risk 9 
of infections in burn, surgical wound, or injury.
21,22
 Silver was chosen as a largely 10 
recognized efficient antimicrobial agent, especially in its nano form.
23–25
 AgNPs, 11 
however, present some drawbacks, such as nanotoxicity, complicated fabrication and 12 
poor colloidal stability.
26
 By contrast, we employed a technologically simple, relatively 13 
fast and ecologically acceptable methodology for simultaneous synthesis and capping of 14 
AgNPs with biopolymers. Our approach yields stable, highly concentrated and 15 
biocompatible hybrid biopolymer-AgNPs dispersions using AC or CS as reducing and 16 
stabilizing agents.
27,28
 The obtained cationic biopolymer-AgNPs were further 17 
incorporated into multilayer assemblies with hyaluronic acid (HA) which were easily 18 
detached as freestanding films from the underlying silicone template without the need of 19 
any post-processing steps. The engineered films were tested for their ability to inhibit the 20 
growth and biofilm formation of the common skin and soft tissue pathogens 21 
Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), without affecting the 22 
human skin cells.
29,30
 23 
 5 
MATERIALS AND METHODS 1 
   Reagents 2 
   Medical grade CS from Agaricus bisporus (Mw ~15 kDa and DDA = 87%) provided by 3 
Kitozyme (Belgium) and the cellulose derivative, 6-deoxy-6-(ω-aminoethyl) 4 
aminocellulose (Mw ~15 kDa) synthesized from microcrystalline cellulose (Fluka, Avicel 5 
PH-101) via a tosyl cellulose intermediate,
28,31
 were used as reducing and capping agents 6 
in the biopolymer-AgNPs synthesis. Sodium salt of hyaluronic acid (HA, Mw ~ 750 kDa) 7 
was purchased from Lifecore Biomedical (USA) and utilized as a polyanion. AgNO3, (3-8 
aminopropyl)triethoxysilane (APTES), acetic acid, sodium chloride (NaCl), hydrochloric 9 
acid (HCl), sodium hydroxide (NaOH), sodium dodecyl sulfate (SDS), 10 
poly(ethyleneimine) (PEI), acetone, ethanol and isopropanol of analytical grade were 11 
purchased from Sigma-Aldrich (Spain). Antimicrobial tests were carried out with Gram-12 
positive S. aureus ATCC® 25923™ and Gram-negative E. coli ATCC® 25922™ 13 
bacteria. Nutrient broth (NB) from Sharlab (Spain) was used as growth medium in all 14 
antibacterial tests, whereas tryptic soy broth (TSB) obtained from Sigma-Aldrich (Spain), 15 
was employed in the biofilm inhibition tests. Baird-Parker and Coliform selective agars 16 
for culturing and enumeration of S. aureus and E. coli, respectively, were also purchased 17 
from Sigma-Aldrich (Spain). Live/Dead® BacLight™ kit (Molecular probes L7012) and 18 
AlamarBlue™ Cell Viability Reagent were obtained from Invitrogen, Life Technologies 19 
Corporation (Spain). Polydimethyl/vinylmethyl siloxane (silicone) strips (ASTM D 1418) 20 
were provided by Degania Silicone Ltd. (Israel). 21 
 6 
   Synthesis and characterization of biopolymer-capped Ag NPs 1 
   Concentrated dispersions of biopolymer-AgNPs (ACAgNPs and CSAgNPs) were 2 
synthesized according to a previously described procedure.
27
 Briefly, 20 mL of aqueous 3 
AgNO3 (2 mg mL
-1
) were mixed with 30 mL of 1% (w/v) aqueous AC solution or 1% 4 
(w/v) CS solution prepared in 1% acetic acid. The pH was adjusted to 5.5 with 3 M 5 
NaOH and the mixtures were sonicated during 3 h with Ti-horn 20 kHz (Sonics and 6 
Materials VC750, USA). The reaction temperature of 60 ºC was maintained with a 7 
thermostatic bath. The US parameters were determined calorimetrically as follows: 8 
intensity 17.30 W cm
-2
, density 0.43 W cm
-3
 and power 21.5 W. 9 
   The spectra of ACAgNPs and CSAgNPs were collected in the 300-600 nm range, 10 
recording the absorbance at a 2 nm step, with a microplate reader Infinite M200 (Tecan, 11 
Austria). The size, polydispersity index and ζ-potential of the NPs were determined using 12 
a Zetasizer Nano ZS (Malvern Instruments Inc., UK). Then, images of the NPs hybrids 13 
were acquired with a Zeiss Neon FIB microscope (Carl Zeiss, Germany) operating in 14 
scanning transmission electron microscopy (STEM) mode at 30 kV acceleration voltage. 15 
Due to the high NPs concentrations, the dispersions were diluted 100-fold and 20 µL 16 
aliquots were drop-casted on the holey carbon grids. 17 
   Fabrication of multilayer antibacterial films 18 
   Multilayer films were fabricated on silicone strips previously washed with 0.5% (w/v) 19 
SDS, distilled water and ethanol. After washings, the silicone surface was amino-20 
functionalized using APTES to allow the deposition of first HA (polyanion) layer via the 21 
 7 
electrostatic interactions between the carboxyl groups of HA and the amino groups on the 1 
surface. The APTES pretreatment of silicone was carried out according to a previously 2 
described procedure.
32
 Cationic ACAgNPs or CSAgNPs dispersions and anionic solution 3 
of HA, with final concentrations of 0.5 mg mL
-1
 were prepared in 0.15 M NaCl. Aqueous 4 
solutions of 1 M HCl and 1 M NaOH were used to adjust the pH of all polyelectrolytes to 5 
5.5. Multi-vessel automated dip coater (KSV NIMA, Finland) was used for automatic 6 
alternate deposition on the silicone strips of 10, 50, 100 and 200 bilayers of HA and 7 
ACAgNPs or CSAgNPs. Each adsorption step lasted 10 min, followed by a 10 min 8 
rinsing in 0.15 M NaCl, pH 5.5. The materials composed of 10 bilayers were considered 9 
coatings, whereas those of 50, 100 and 200 bilayers were called films. The biocomposites 10 
were designated as HA-ACAgNPs when ACAgNPs hybrid was used as a polycation and 11 
HA-CSAgNPs in case of CSAgNPs hybrid. The samples were further thoroughly washed 12 
with distilled water and after drying at room temperature, the films were detached from 13 
the silicone strips and subjected to specific analyses.  14 
   Monitoring of multilayer assembly with quartz crystal microbalance with dissipation 15 
   The LbL build-up of HA and ACAgNPs or CSAgNPs was followed in situ with a 16 
quartz crystal microbalance with dissipation (QCM-D, E4 system, Q-Sense, Sweden). 17 
The deposition was performed onto gold coated sensor crystals QSX 301 (QSense, 18 
Sweden) at 22 ºC and at a constant flow rate (80 µL min
-1
). Prior LbL assembly, the 19 
crystals were cleaned successively by US bath in acetone, ethanol and isopropanol for 10 20 
min at 40 ºC. Thereafter, the crystals were incubated overnight at room temperature in 1 21 
 8 
mg mL
-1
 PEI solution for amino functionalization of their surface. The modified sensors 1 
were washed, dried under nitrogen stream and placed in the QCM-D flow chambers.  2 
The baseline was carried with 0.15 M NaCl, pH 5.5. The multilayer assembly of 3 
ACAgNPs or CSAgNPs and HA was repeated 5 times to obtain 5 bilayers on the amino-4 
functionalized crystals. To simplify the data interpretation, only the normalized frequency 5 
(Δf/Ȟ) and dissipation (ΔD) shifts as a function of time of one representative sample per 6 
experimental group (5
th
 harmonic) is shown.  7 
   Characterization of the multilayer films 8 
   Attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) was 9 
used to characterize the multilayer materials. For this purpose, the AC- and CS-based 10 
coatings of 10 bilayers were analyzed in a Spectrum 100 FT-IR spectrometer (Perkin 11 
Elmer, USA). The spectra were obtained between 4000-625 cm
-1
 performing 64 scans at 12 
4 cm
-1
 resolution. Prior to the FTIR analysis the specimens were dried under nitrogen 13 
until no water was detected during the analyses. 14 
   The dry thickness of the LbL coatings on the silicone support and the films were further 15 
investigated by scanning electron microscopy (SEM) (JSM 5610, JEOL Ltd, Japan). The 16 
cross sections of the film were obtained by a single cut of the dried under nitrogen 17 
specimens. The surface morphology of the films was studied by field emission SEM 18 
(FESEM) JEOL J-7100 with Energy-dispersive X-ray spectroscopy (EDS) detector. 19 
Atomic force microscopy (AFM) topographic images of the nanobiocomposites were 20 
acquired in an air tapping mode using a Multimode AFM controlled by Nanoscope IV 21 
 9 
electronics (Veeco, Santa Barbara, CA) under ambient conditions. Triangular AFM 1 
probes with silicon nitride cantilevers and silicon tips were used (SNL-10, Bruker) 2 
(nominal spring constant of 0.35 N/m and a resonant frequency of 50 kHz). Images were 3 
acquired at 1 Hz line frequency and at minimum vertical force to reduce sample damage. 4 
The surface roughness was calculated from the acquired images with Nanoscope Analysis 5 
1.5 software.  6 
   The total amount and the cumulative release of silver from the freestanding 7 
multilayered films (100 and 200 bilayers) were determined with an inductively coupled 8 
plasma mass spectrometry (ICP-MS) calibrated by internal standard with 
115
In and a 9 
standard curve of 
107
Ag. For silver quantification the films were cut (1 x 1 cm
2
) and 10 
digested with 20 % HNO3. The cumulative release of silver ions from the films was 11 
studied in phosphate-buffered saline (PBS) over seven days. The films (1 x 1 cm
2
) were 12 
incubated in 40 mL 0.01 M PBS, pH 7 at 37 ºC. At defined time intervals 1 mL of the 13 
solution was collected and acidified with HNO3 before analysis with ICP-MS 14 
(PerkinElmer Ltd.).  15 
   Inhibition of bacteria growth 16 
   The potential of the multilayer coatings and films to inhibit the bacterial growth was 17 
assessed by a standard flask shake method (ASTM-E2149-01).
33
 Single colonies isolated 18 
on tryptic soy agar plates by streaking technique were used in order to prepare S. aureus 19 
and E. coli cultures. The cultures were then inoculated overnight in 5 mL sterile NB and 20 
incubated at 37 ºC and 110 rpm. The inoculated bacteria cultures were diluted in sterile 21 
0.3 mM potassium dihydrogen phosphate, pH 7.2 (KH2PO4) until absorbance of 0.28 ± 22 
 10 
0.01 at 475 nm was reached, which corresponds to 1.5 - 3.0 x 10
8
 colony-forming unit 1 
(CFU) per mL. Thereafter, the silicone coated with 10 bilayers coatings and the films 2 
were cut in 1 x 1 cm
2
 pieces that were incubated with 5 mL of bacterial suspension (final 3 
concentration 1.5 - 3.0 x 10
5
 CFU mL
-1
) at 37 ºC and 230 rpm for 1 h. The determination 4 
of the inoculum cell density of the suspensions was carried out by withdrawing part of the 5 
suspension before introducing the pieces and after 1 h in contact with them. The 6 
withdrawn suspensions were serially diluted in sterile buffer solution, plated on a Baird-7 
Parker agar or Coliform agar and incubated at 37 ºC for 24 h to determine the number of 8 
viable bacteria. The antibacterial activity is reported in terms of percentage of bacterial 9 
reduction calculated as the ratio between the number of bacteria before and after the 10 
contact with the samples using the following equation: 11 
Reduction of viable bacteria (%) = ((A-B) / A) x 100 12 
where A and B are the average number of viable bacterial cells (i.e. counted CFU) before 13 
and after the contact with the multilayer materials, respectively. 14 
   Inhibition of bacterial biofilms 15 
   The ability of the developed multilayer materials to counteract pathogenic biofilm 16 
formation of S. aureus and E. coli was studied by fluorescence microscopy and viability 17 
counts. Overnight-grown cultures of S. aureus and E. coli were diluted in TSB to an 18 
optical density (O.D.)600 = 0.01, corresponding to ~ 2 x 10
5
 CFU mL
-1
. The multilayer-19 
coated silicone strips and films were cut into 1×1 cm
2
 pieces and placed in a 24-well 20 
plate. Then, 1 mL of the bacterial suspension was inoculated in each well, and the plate 21 
 11 
was incubated for 24 h at 37 ºC. The biofilms were washed with 1 mL 0.9% NaCl 1 
solution pH 6.5 three times and the biofilm growth on the materials was assessed 2 
measuring the fluorescence at 480/500 nm after 15 min staining with a mixture of green 3 
fluorescent Syto 9 and red-fluorescent Propidium iodide stains (1:1) of Live/Dead® 4 
BacLight™ kit.  5 
   S. aureus and E. coli biofilms grown for 24 h on the films were also quantitated by 6 
direct enumeration of the live bacteria. The non-attached cells were rinsed (3x) with 1 mL 7 
of sterile 0.9% NaCl, pH 6.5 and the samples were transferred into sterile tubes 8 
containing 2 mL 0.9% NaCl, pH 6.5. Then, the tubes were placed in an ultrasonic bath for 9 
20 min and the viable counts were performed by plating bacterial suspension on selective 10 
agar plates.  11 
   Biocompatibility assessment 12 
Human foreskin fibroblasts (ATCC
®
-CRL-4001
™
, BJ-5ta) and keratinocytes (HaCaT cell line) 13 
were used to assess the biocompatibility of the films. The cells were maintained in 4 parts 14 
Dulbecco’s Modified Eagle’s Medium (DMEM, ATCC) containing 4 mM of L-glutamine 15 
(ATCC), 4500 mg L
-1
 glucose, 1500 mg L
-1
 sodium bicarbonate and 1 mM sodium 16 
pyruvate, and 1 part of Medium 199 supplemented with 10% (v/v) of fetal bovine serum 17 
and 10 g mL
-1
 hygromycin B, at 37 °C in a humidified atmosphere with 5% CO2. At pre-18 
confluence, the cells were harvested using trypsin-EDTA (ATCC-30-2101, 0.25% (w/v) 19 
trypsin/0.53 mM EDTA solution in Hank’s BSS without calcium or magnesium) and 20 
seeded at a density of 5.1 x 10
4
 cells/well on a 24-well tissue culture treated polystyrene 21 
 12 
plate (Nunc). After 24 h, the cells were washed twice with sterile PBS; the samples were 1 
placed in the wells and 1 mL of complete growth medium (DMEM) were added. The 2 
cells were incubated at 37°C for 1 and 7 days. At the end of these periods, the samples 3 
were removed, the growth media withdrawn and the cells were washed twice with PBS 4 
and stained for 4 h at 37°C with 100 ȝL 10% (v/v) AlamarBlue™ Cell Viability Reagent 5 
in DMEM. After that, the absorbance at 570 nm was measured, using 600 nm as a 6 
reference wavelength, in a microplate reader. The quantity of resorufin formed is directly 7 
proportional to the number of viable cells. Cells relative viability (%) was determined for 8 
each sample and compared with that of cells incubated only with culture medium. H2O2 9 
(500 ȝM) was used as a positive control of cell death. Data are expressed as the mean of 10 
three measurements, with a standard deviation as a source of error. 11 
 12 
RESULTS AND DISCUSSION 13 
   Synthesis of concentrated biopolymer-AgNPs dispersions 14 
In our previous work, AgNPs capped with CS (CSAgNPs) were sonochemically 15 
synthesized in a 3-hours process at 60 ºC. Concentrated NPs suspension with more than 6 16 
months stability was obtained.
27
 For the purpose of the current study, NPs dispersions of 17 
both ACAgNPs and CSAgNPs were generated and used to construct supramolecular 18 
materials by LbL assembling. Besides of CS, the synthesis/stabilization approach for 19 
AgNPs production was extended to the application of another cationic polysaccharide 20 
under the same sonochemical processing conditions. The NPs formation was confirmed 21 
by UV-Vis spectroscopy displaying absorbance peaks of similar intensity at around 420 22 
nm (Fig. 1) derived from the typical excitation of surface plasmon vibrations of Ag 23 
 13 
atoms. The biopolymer-capped AgNPs were spherical in shape with size about 100 nm 1 
(Fig. 1, inset STEM images), low polydispersity index and high ζ-potential (Table S1). 2 
The absence of NPs complexes in STEM images further confirmed their high stability to 3 
aggregation. It is worthy to mention that some aggregation was expected to occur during 4 
drying the dispersions on the TEM grids. 5 
 6 
Figure 1. UV-vis spectra and STEM images of ACAgNPs and CSAgNPs dispersions 7 
synthesized under sonication during 3 h at 60 ºC. The scale bars correspond to 1000 nm.  8 
In situ monitoring of the multilayer build-up 9 
   ACAgNPs and CSAgNPs with high positive charge density and large surface to volume 10 
ratio were further used as both building element and antibacterial active agent in the 11 
bottom up LbL fabrication of functional freestanding composite films. The films were 12 
 14 
LbL assembled on template surfaces by the alternating deposition of positively charged 1 
CS- or AC-capped AgNPs and negatively charged hyaluronic acid (HA). 2 
   The LbL build-up of HA and ACAgNPs or CSAgNPs was assessed in situ with a 3 
QCM-D. The frequency (Δfn) and dissipation (ΔDn) changes obtained at the 5th overtone 4 
during layers assembling onto a PEI-functionalized gold crystal are shown in Fig. 2. The 5 
stepwise decrease in Δf5 and increase of ΔD5 after each deposition step confirmed the 6 
successful deposition of the anionic HA and cationic biopolymer-AgNPs in a LbL 7 
fashion. The changes in Δf5 and ΔD5 confirmed the effective interaction between building 8 
elements and suggested an exponential growth of the multilayer films comprising low- 9 
and high-Mw compounds.
11
 Moreover, the washing of the weakly adsorbed compounds 10 
after each deposition step led to negligible changes in the Δf5 and ΔD5 values, indicating 11 
strong interaction between the biopolymer-AgNPs and HA and consequent formation of 12 
stable assemblies. Such behavior highlights the possibility of using small positively 13 
charged  nano-sized entities as anchoring points for formation of stable multilayers that 14 
can be easily detached from the substrate template to form freestanding films. 15 
Remarkably, the variations in Δf5 and ΔD5 are more pronounced in the constructs where 16 
CSAgNPs are present, which is correlated with the formation of thicker layers. CSAgNPs 17 
possess enhanced cationic character in comparison to ACAgNPs owing to the higher pKa 18 
of CS (pKa ~ 6.5)
34
 vs AC (pKa ~ 5.2)
35
 and therefore induce stronger electrostatic 19 
interactions with HA, favoring the coating build-up. The continuous increase in the ΔD5 20 
on the other hand indicated that the assembled multilayers are soft and demonstrate 21 
damping properties similar to other polymeric systems. 22 
 15 
 1 
Figure 2. QCM-D monitoring of normalized frequency (Δf5) and dissipation (ΔD5) 2 
obtained at 5th overtone as a function of time during the build-up of 5 HA-CSAgNPs and 3 
HA-ACAgNPs bilayers. 4 
Fabrication and characterization of the NPs-containing multilayer nanobiocomposites 5 
   ACAgNPs and CSAgNPs (as polycations) were sequentially deposited on the surface of 6 
APTES-functionalized silicone strips using HA as an alternate polyanion. Unlike the 10 7 
bilayers, the 50 and especially the 100 and 200 bilayer films, could be easily detached 8 
from the silicone substrate, without any post-treatment, and handled for further analyses 9 
(Fig. 3III).  10 
 16 
 1 
Figure 3. Fabrication of freestanding nanobiocomposite films from HA-ACAgNPs or 2 
HA-CSAgNPs (I and II), and their detachment from silicone (III). AgNPs are oversized in 3 
the scheme to illustrate the concept for the multilayer build-up. Photographs of the 4 
coatings/freestanding films are also shown (IV). 5 
   Since it was not expected that the increasing number of layers would influence the 6 
infrared spectra of the coatings,
7
 the ATR-FTIR was performed only on the 10 bilayer 7 
constructs. The deposition of HA-ACAgNPs and HA-CSAgNPs was evidenced by the 8 
appearance of several new bands compared to the aminated silicone control surface (Fig. 9 
4). 10 
 17 
 1 
Figure 4. ATR-FTIR spectra of APTES-treated silicone control and the silicones coated 2 
with 10 bilayers of HA-ACAgNPs (grey dashed line) and HA-CSAgNPs (black dashed 3 
line). 4 
   These peaks were related to the presence of cationic polyelectrolytes (AC or CS) and 5 
the polyanion (HA), as well as the interactions between them. The peaks at around 2900 6 
and 1346 cm
-1
 come from the stretching vibrations (-NH) in amino groups of AC or CS, 7 
while the peak at 1420 cm
-1
 belongs to both hydroxyl (-OH) and alkyl (-CH2) group 8 
deformations in the cyclic structures of the three polysaccharides (AC, CS and HA). 9 
These peaks confirmed that the multilayer structures comprised both cationic and anionic 10 
polyelectrolytes. The interaction of the oppositely charged components in the coatings led 11 
to the appearance of the band at 3500 cm
-1
, owing to the stretching of hydroxyl groups (-12 
OH) involved in hydrogen bonding between the carboxylic groups from HA and the 13 
 18 
amine groups in AC or CS.
36
 Such interaction was corroborated by the appearance of the 1 
bands at 1627 and 1570 cm
-1
, assigned to the typical amide I and amide II, respectively. 2 
   The SEM images taken at the cross-section of the LbL materials showed that 10 3 
alternate depositions (coatings) were not sufficient to obtain an even coverage of the 4 
silicone surface, regardless of the choice of the polycation (AC or CS) (Fig. 5). In these 5 
cases a dry thicknesses of ~1 µm was measured on isolated islets, emerged from the 6 
coated silicone surface. These islets grow in diameter with increasing number of 7 
deposited layers and eventually coalesce into continuous coatings in the so-called “second 8 
stage” of the build-up process, usually above 10-20 bilayers.37 9 
 10 
 19 
Figure 5. SEM micrographs of cross-sections of the representative coatings and 1 
freestanding LbL nanobiocomposite films comprising different number of bilayers: HA-2 
ACAgNPs (left column), HA-CSAgNPs (right column). Magnification x5000. 3 
   For the nanobiocomposite constructs with ≥50 bilayers, a reasonably homogeneous 4 
deposition of the last layer was revealed by SEM. In fact, the dry thickness of the AgNPs-5 
containing films gradually increased with the increasing number of deposited bilayers. 6 
The thickest films were expectedly those comprised of 200 bilayers (Table 1 and Fig. 5), 7 
especially valid for the films containing CSAgNPs.  8 
Table 1. Average thickness of HA-ACAgNPs and HA-CSAgNPs multilayer coatings and 9 
films 10 
 11 
Coating/Membrane Nº of bilayers Thickness 
HA-ACAgNPs 10 ~1.1 µm 
 
50 2.9 µm 
100 8.5 µm 
 
200 16.1 µm 
HA-CSAgNPs 10 ~1.2 µm 
50 5.8 µm 
100 12.5 µm 
 20 
200 24.2 µm 
The nanobiocomposite constructs with 100 and 200 bilayers displayed a homogeneous 1 
surface topography (Fig. 6 and Fig. S1) in agreement with previous SEM observations 2 
(Fig. 5). In contrast to the HA-ACAgNPs films, silver NPs of ≈100 nm were clearly 3 
observed on the surface of CS-based constructs, further confirmed by the EDS analysis 4 
(Fig. S2). The root mean square roughness (Rq) obtained from the AFM images revealed 5 
a decrease in the surface irregularities with the deposition of more HA/biopolymer 6 
AgNPs bilayers (Table S2). Previous studies in our group showed the same tendency for 7 
multilayer assembled with cationic nano-sized entities.
7
 8 
 9 
Figure 6. Topographic AFM images (5 x 5 µm) of the freestanding LbL 10 
nanobiocomposite films comprising 200 bilayers: A) HA-ACAgNPs and B) HA-11 
CSAgNPs. 12 
 21 
ICP-MS measurements quantified the total amount and the release of silver from the 1 
freestanding films. The 100 and 200 bilayers LbL films comprising CSAgNPs contain 2 
more silver (0.19 % and 0.44 % (w/w)) than those with ACAgNPs (0.01 % and 0.02 % 3 
(w/w)), respectively. The strong electrostatic interactions of CSAgNPs with anionic HA 4 
results in more mass deposition, including AgNPs and HA, and formation of thicker 5 
films, as confirmed by QCM-D (Fig. 2) and SEM (Fig. 5). Nevertheless, very similar 6 
release profiles were observed in each group of studied films, e.g. CS or AC containing, 7 
showing an initial burst release over the first 24 h followed by a sustained release during 8 
a week (Fig. 7). After 7 days of incubation, higher silver release, 371 and 278 ppb, was 9 
detected for HA-CSAgNPs films with 200 layers and 100 layers, respectively. On the 10 
other hand, only 158 and 60 ppb of silver were released from HA-ACAgNPs comprised 11 
of respectively 200 and 100 bilayers. Such noticeable difference in the amount of silver 12 
released from these films over 7 days is related to the total load of ACAgNPs and 13 
CSAgNPs in each specimen. The sustained release profiles of antibacterial silver make 14 
the LbL films suitable for limiting the growth and spread of bacterial pathogens on non-15 
living and living surfaces.  16 
 22 
 1 
Figure 7. Cumulative silver release from HA-ACAgNPs and HA-CSAgNPs films. 2 
  Antibacterial effect 3 
   Since AgNPs are widely known as efficient antibacterial agents against both Gram-4 
positive and Gram-negative bacteria, the antibacterial efficiency of the LbL coatings and 5 
films was evaluated against the medically relevant representative of skin infections - S. 6 
aureus and E. coli.
29,30
 All LbL films, i.e. HA-ACAgNPs or HA-CSAgNPs with ≥ 50 7 
bilayers, displayed full kill (100% viability reduction) for both bacterial strains, whereas 8 
the 10 bilayers coatings were not as efficient apparently due to the lower concentration of 9 
the antibacterial agent (Fig. 8 and Fig. S3).  10 
 23 
 1 
Figure 8. Reduction of S. aureus and E. coli viability using HA-ACAgNPs and HA-2 
CSAgNPs films comprising 100 and 200 bilayers. 3 
   The adhesion of S. aureus and E. coli and subsequent establishment of bacterial 4 
biofilms on the films was further assessed by fluorescence microscopy and viable cell 5 
counts. The nanobiocomposites inhibited the biofilm growth to a different extent as 6 
compared to pristine silicone, on which the individual cells formed robust sessile bacterial 7 
communities (Fig. 9). Although the LbL coatings with 100 bilayers of HA-ACAgNPs or 8 
HA-CSAgNPs significantly reduced S. aureus and E. coli biofilms compared to the 9 
 24 
pristine silicone, their surface was still colonized with bacterial clusters. Further increase 1 
in the number of bilayers to 200 considerably improved the antibiofilm activity of the 2 
films. The build-up of 200 bilayers brought about the total prevention of the S. aureus and 3 
E. coli biofilm formation on HA-CSAgNPs, reducing the viable cells on the surface by 7 4 
logs and 6 logs, respectively (Fig. S4). However, 200 bilayers freestanding films with 5 
ACAgNPs demonstrated even lower antibiofilm activity towards Gram-negative E. coli, 6 
as more bacterial clusters on the surface were observed (Fig. 9). These findings were 7 
further confirmed by enumeration of the surface attached viable E. coli cells (Fig. S4). In 8 
general, Gram-positive bacteria are considered more resistant to AgNPs than Gram-9 
negative ones due to the thick peptidoglycan layer in their cell wall, which serves as a 10 
protective barrier and limits the NPs uptake.
38
 However, capping AgNPs with cationic 11 
biopolymers promotes the interaction with the negatively charged bacterial cells, and 12 
together with Ag synergistically increases the bactericidal potential of the hybrids. We 13 
have already shown the ability of cationic AC and thiolated CS NPs to disrupt bacterial 14 
membrane, leading to cells death at lower concentrations.
39
 Herein, the films composed of 15 
CS or AC capped AgNPs affected in a similar fashion the growth of free-floating 16 
(planktonic) S. aureus and E. coli cells (Fig. 8). By contrast, their antibiofilm potential 17 
was higher towards S. aureus, which may be attributed to the presence of HA as already 18 
observed in previous works.
5,40
 However, bacterial attachment and biofilm formation on 19 
surfaces is a more complex processes governed by a large number of factors including 20 
surface charge, hydrophobicity and roughness.
41
 Smooth top layers, such as those of the 21 
films (Fig. 5 and 6, Table S2), are known to decrease the non-specific protein attachment 22 
and bacterial colonization.
42–44
 Indeed, creating a smooth nanostructured surface was our 23 
 25 
goal to prevent the bacterial adhesion, since most of the natural anti-biofilm surfaces 1 
reported to date are known to possess well-organized micro/nanoscale surface patterns at 2 
a “sub-bacterial” scale, i.e. < 1 ȝm in length.44,45 Other strategies to control bacterial 3 
colonization range from anti-adhesive surfaces that aim at preventing the host proteins 4 
adherence and repelling bacteria,
46
 to antibacterial materials able to kill pathogens either 5 
upon release of the biocide or at contact with bacteria cells.
47,48
 The smooth membrane 6 
surface, the controlled antimicrobial silver release, and the presence of antifouling HA 7 
and hybrid-biopolymer NPs in the multilayers synergistically improve the 8 
antibacterial/antibiofilm potential of the engineered nanobiocomposite films.  9 
 10 
Figure 9. Antibiofilm activity of films. Fluorescence microscopy images (x10 11 
magnification) after Live/Dead staining of S. aureus and E. coli biofilms on silicone 12 
control and on HA-ACAgNPs and HA-CSAgNPs multilayer nanobiocomposites. The 13 
scale bar corresponds to 100 µm. 14 
 15 
 26 
Biocompatibility of the films 1 
AgNPs are among the approved by the U.S. Food and Drug Administration nano-devices 2 
for antibacterial applications, e.g. in wounds. However, as human exposure to NPs 3 
increased, their nanotoxicity became an emerging and growing concern. Size, shape, and 4 
surface chemistry/coating greatly affect the potential risk related to their short- and long-5 
term toxicity.
49,50
 The bioavailability of silver ions (Ag
+
) from AgNPs is considered as a 6 
major factor in Ag-mediated toxicity.
51,52
 We have previously reported that hybrid 7 
nanomaterials comprising metal NPs (ZnO) and antimicrobial biopolymer (namely CS) 8 
exhibit very low toxicity coupled to high antimicrobial efficiency.
33
 Similarly to the 9 
current study, integrating metal NPs with biopolymers with intrinsic antimicrobial 10 
properties resulted in reduced cytotoxicity due to the low dissolution rates of the metal 11 
from such complexes.
53,54
 12 
Here, the biocompatibility of the developed films was evaluated with human skin 13 
fibroblasts and keratinocytes (Fig. 10). After one week of contact, both cell lines were 14 
metabolically active with no significant difference in cell viability (above 90 %) observed 15 
among the experimental groups. The only exception was for the HA-CSAgNPs 16 
membrane with 200 bilayers, which did not induce considerable cell toxicity either, but 17 
the cell viability decreased to the still above the acceptable for biomedical applications 80 18 
% after 7 days. 19 
 27 
 1 
Figure 10. Viability of A) fibroblasts and B) keratinocytes in presence of HA-ACAgNPs 2 
and HA-CSAgNPs films of 100 and 200 bilayers. 3 
Conclusions 4 
In this study, the LbL approach was exploited to fabricate freestanding nanobiocomposite 5 
films with strong antibacterial and antibiofilm activities against common skin pathogens. 6 
 28 
Their antibacterial efficiency is due to the polycation-decorated AgNPs embedded 1 
alternately between polyanion HA layers. Prior to their inclusion into the films, the 2 
polycationic NPs were synthesized using sonochemistry to complete the overall 3 
environmentally friendly approach for the fabrication of functional and safe to human 4 
skin cells nanobiocomposite films. The NPs played both i) a structural role to stabilize the 5 
final 3D supramolecular nanobiocomposite, and ii) a functional role as a source of 6 
antibacterial silver ions. The obtained organic-inorganic multilayer film composites 7 
completely inhibited the planktonic growth and biofilm formation by Gram-positive S. 8 
aureus and Gram-negative E. coli pathogens. These features, coupled to their excellent 9 
biocompatibility pave the way for their further application as protective dressings for skin 10 
injuries to kill bacteria and reduce the risk of infection occurrence. 11 
    12 
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